YBGJ Yubo International Biotech Limited
Fundamentals / CIK 0000895464 / USDYubo International Biotech Limited reported $12K in revenue and a net loss of $970K for the trailing twelve months ended September 30, 2026 (up 256.0% year over year), with a 66.1% gross margin and a -8232.7% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open YBGJ in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$12K +256.0% YoY
-
Operating Income TTM-$1.02M -8232.7% margin
-
Net Income TTM-$970K -7855.2% net margin
-
Diluted EPS TTM-$0.01 Split-adjusted
-
Free Cash Flow TTM-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026-- Total debt: --
Annual revenue and net income
10 fiscal years (2017 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Feb 29 | Feb 28 | Feb 28 | Feb 28 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12K | $3.5K | $605K | $104K | $1.24M | -- | $0 | $0 | $0 | $0 |
| Cost of Revenue | $4.2K | $822 | $185K | $52K | $424K | $114K | -- | -- | -- | -- |
| Gross Profit | $8.2K | $2.6K | $419K | $53K | $821K | $1.24M | -- | -- | -- | -- |
| Selling, General & Admin | -- | -- | -- | -- | -- | -- | $29K | $48K | $58K | $149K |
| Total Operating Expenses | $1.20M | $1.77M | $1.61M | $1.26M | $2.36M | $1.95M | -- | -- | -- | -- |
| Operating Income | -$1.19M | -$1.77M | -$1.19M | -$1.21M | -$1.54M | -$712K | -$29K | -$48K | -$58K | -$149K |
| EBITDA | -$1.02M | -$1.60M | -$1.02M | -$1.19M | -$1.53M | -$699K | -- | -- | -- | -- |
| Interest Expense | -- | -- | -- | -- | -- | -- | $105K | $100K | $86K | $75K |
| Income Before Tax | -$1.19M | -$1.98M | -$1.20M | -$1.20M | -$1.54M | -- | -- | -- | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$1.08M | -$1.78M | -$1.20M | -$1.20M | -$1.54M | -$712K | -$134K | -$148K | -$144K | -$224K |
| Basic EPS | -- | -- | -- | -- | -- | -- | -$0.11 | -$0.13 | -$0.12 | -$0.19 |
| Diluted EPS | -$0.01 | -$0.02 | -$0.10 | -- | -- | -- | -$0.11 | -$0.13 | -$0.12 | -$0.19 |
| Basic Shares Outstanding | -- | -- | -- | -- | -- | -- | 1.2M | 1.2M | 1.2M | 1.2M |
| Diluted Shares Outstanding | 139.6M | 119.8M | 12.0M | -- | -- | -- | 1.2M | 1.2M | 1.2M | 1.2M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $12K | $0 | $0 | $0 | -$18 |
| Cost of Revenue | $0 | $0 | $0 | $4.2K | $0 | $0 | $0 | -$5 |
| Gross Profit | $0 | $0 | $0 | $8.2K | $0 | $0 | $0 | -$13 |
| Total Operating Expenses | $203K | $239K | $289K | $294K | $310K | $250K | $467K | $357K |
| Operating Income | -$203K | -$239K | -$289K | -$285K | -$310K | -$250K | -$467K | -$357K |
| EBITDA | -$203K | -$238K | -$264K | -$243K | -$268K | -$208K | -$426K | -$318K |
| Interest Expense | -- | -- | -- | -- | $18 | $23 | -- | -- |
| Income Before Tax | -$204K | -$269K | -$295K | -$286K | -$310K | -$250K | -$467K | -$353K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$188K | -$248K | -$273K | -$261K | -$277K | -$230K | -$436K | -$147K |
| Diluted EPS | $0.00 | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- |
| Diluted Shares Outstanding | 170.4M | 170.4M | 170.4M | -- | 147.9M | 119.8M | 119.8M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Feb 29 | Feb 28 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $8.1K | $7.0K | $6.4K | $18K | $28K | $1.38M | $1.0K | $4.0K |
| Cash & Short-Term Investments | $8.1K | $7.0K | $6.4K | $18K | $28K | $1.38M | $1.0K | $4.0K |
| Accounts Receivable, Net | $138K | $165K | $80K | $52K | $162K | $2.3K | -- | -- |
| Inventory | $24K | $37K | $215K | $322K | $164K | $67K | -- | -- |
| Total Current Assets | $668K | $683K | $725K | $750K | $1.06M | $1.91M | $1.0K | $4.0K |
| Property, Plant & Equipment, Net | $43K | $206K | $375K | $617K | $644K | $79K | -- | -- |
| Intangible Assets | $42K | $51K | $54K | $68K | $39K | $55K | -- | -- |
| Total Non-Current Assets | $180K | $852K | $942K | $1.60M | $3.53M | $536K | $0 | $0 |
| Total Assets | $847K | $1.53M | $1.67M | $2.35M | $4.59M | $2.44M | $1.0K | $4.0K |
| Accounts Payable | -- | -- | -- | -- | -- | -- | $353K | $342K |
| Total Current Liabilities | $2.79M | $4.72M | $3.40M | $2.52M | $2.79M | $1.28M | $1.80M | $1.67M |
| Total Non-Current Liabilities | $0 | $111K | $116K | $390K | $1.93M | $0 | $0 | $0 |
| Total Liabilities | $2.79M | $4.83M | $3.51M | $2.91M | $4.72M | $1.28M | $1.80M | $1.67M |
| Total Debt (incl. Leases) | $79K | $479K | $392K | $790K | $294K | $315K | -- | -- |
| Common Stock | -- | -- | -- | -- | -- | -- | -- | $1.0K |
| Retained Earnings | -$7.74M | -$6.66M | -$4.89M | -$3.69M | -$2.49M | -$943K | -$29.09M | -$28.95M |
| Accumulated Other Comp. Income | $146K | $127K | -$13K | $70K | $118K | $2.0K | -- | -- |
| Total Stockholders' Equity | -$1.95M | -$3.42M | -$1.84M | -$565K | -$131K | $1.17M | -$1.80M | -$1.66M |
| Total Equity | -$1.94M | -$3.30M | -$1.84M | -$565K | -$131K | $1.17M | -$1.80M | -$1.66M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | -- | $12K | $10K | $8.1K | $11K | $10K | $9.8K | $7.0K |
| Cash & Short-Term Investments | -- | $12K | $10K | $8.1K | $11K | $10K | $9.8K | $7.0K |
| Accounts Receivable, Net | $123K | $138K | $134K | $138K | $114K | $118K | $147K | $165K |
| Inventory | $22K | $25K | $24K | $24K | $38K | $38K | $37K | $37K |
| Total Current Assets | $579K | $583K | $598K | $668K | $650K | $659K | $685K | $683K |
| Property, Plant & Equipment, Net | $17K | $17K | $18K | $43K | $85K | $126K | $166K | $206K |
| Intangible Assets | $39K | $40K | $39K | $42K | $43K | $45K | $48K | $51K |
| Total Non-Current Assets | $72K | $89K | $112K | $180K | $304K | $392K | $481K | $852K |
| Total Assets | $651K | $672K | $710K | $847K | $953K | $1.05M | $1.17M | $1.53M |
| Total Current Liabilities | $3.55M | $3.33M | $3.02M | $2.79M | $2.56M | $5.03M | $4.78M | $4.72M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $7.8K | $31K | $111K |
| Total Liabilities | $3.55M | $3.33M | $3.02M | $2.79M | $2.56M | $5.03M | $4.81M | $4.83M |
| Total Debt (incl. Leases) | -- | $16K | $39K | $79K | $139K | $185K | $231K | $479K |
| Retained Earnings | -$8.45M | -$8.26M | -$8.01M | -$7.74M | -$7.48M | -$7.33M | -$7.10M | -$6.66M |
| Accumulated Other Comp. Income | -$40K | -$1.3K | $76K | $146K | $176K | $217K | $318K | $127K |
| Total Stockholders' Equity | -$2.85M | -$2.62M | -$2.30M | -$1.95M | -$1.66M | -$4.00M | -$3.67M | -$3.42M |
| Total Equity | -$2.90M | -$2.66M | -$2.31M | -$1.94M | -$1.60M | -$3.86M | -$3.65M | -$3.30M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Feb 29 | Feb 28 | Feb 28 | Feb 28 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$1.19M | -$1.98M | -$1.20M | -$1.20M | $1.54M | -$712K | -$134K | -$148K | -$144K | -$224K |
| Depreciation & Amortization | $168K | $170K | $178K | $18K | $13K | $13K | -- | -- | -- | -- |
| Change in Receivables | $27K | -$85K | -$28K | -$110K | $160K | $2.3K | -- | -- | -- | -- |
| Change in Inventory | $13K | $178K | $108K | $158K | -$97K | $67K | -- | -- | -- | -- |
| Operating Cash Flow | -$843K | -$1.34M | -$739K | -$601K | -$1.02M | $101K | -$22K | -$32K | -$55K | -$55K |
| Capital Expenditure | -- | -- | -- | $0 | -$565K | -$43K | -- | -- | -- | -- |
| Free Cash Flow | -- | -- | -- | -$601K | -$1.59M | $59K | -- | -- | -- | -- |
| Investing Cash Flow | $0 | $118K | $0 | -$40K | -$565K | -$97K | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $850K | $1.41M | $746K | $669K | $127K | $1.38M | $19K | $34K | $56K | $45K |
| Net Change in Cash | $1.0K | $656 | -$12K | -$9.3K | -$1.36M | $1.38M | -$3.0K | $2.0K | $1.0K | -$10K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$204K | -$269K | -$295K | -$286K | -$310K | -$250K | -$467K | -$353K |
| Depreciation & Amortization | $650 | $793 | $26K | $43K | $42K | $42K | $42K | $39K |
| Change in Receivables | $15K | -$3.8K | $3.8K | -$24K | $3.7K | $29K | $18K | -- |
| Change in Inventory | -- | $0 | $0 | -- | -- | -$438 | -$259 | $186K |
| Operating Cash Flow | -$157 | -$84K | -$207K | -$129K | -$308K | -$14K | -$392K | -$933K |
| Capital Expenditure | -- | -- | $0 | -- | -- | -- | -$6.2K | -- |
| Free Cash Flow | -- | -- | -$207K | -- | -- | -- | -$398K | -- |
| Investing Cash Flow | $0 | $0 | $0 | -$80K | $0 | $86K | -$6.2K | $0 |
| Financing Cash Flow | $11K | $77K | $215K | $376K | $0 | $196K | $278K | $1.11M |
| Net Change in Cash | -$2.5K | $1.6K | $2.3K | -$2.9K | $510 | $643 | $2.8K | -$1.0K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Feb 29 | Feb 28 | Feb 28 | Feb 28 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.1% | 76.3% | 69.3% | 50.5% | 65.9% | -- | -- | -- | -- | -- |
| Operating Margin | -9614.6% | -51006.3% | -197.6% | -1155.7% | -124.0% | -- | -- | -- | -- | -- |
| Net Profit Margin | -8736.7% | -51171.4% | -197.6% | -1155.5% | -124.0% | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -61.0% | -- | -- | -- | -- |
| Return on Assets (ROA) | -127.4% | -115.7% | -71.7% | -51.3% | -33.6% | -29.1% | -13400.0% | -3700.0% | -- | -- |
| Current Ratio | 0.24x | 0.14x | 0.21x | 0.30x | 0.38x | 1.49x | 0.00x | 0.00x | -- | -- |
| Quick Ratio | 0.23x | 0.14x | 0.15x | 0.17x | 0.32x | 1.44x | 0.00x | 0.00x | -- | -- |
| Debt to Equity | -- | -- | -- | -- | -- | 0.27x | -- | -- | -- | -- |
| Revenue Growth (YoY) | +256.0% | -99.4% | +479.8% | -91.6% | -- | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +208.3% | -99.4% | +696.1% | -93.6% | -33.8% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -1109.7% | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -2808.0% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.1% | 66.1% | 66.1% | 66.1% | -- | -- | -- | 76.3% |
| Operating Margin | -8232.7% | -9096.9% | -9184.6% | -10625.8% | -- | -- | -- | -51006.3% |
| Net Profit Margin | -7855.2% | -8570.8% | -8428.2% | -9747.9% | -- | -- | -- | -48201.8% |
| Return on Assets (ROA) | -149.0% | -157.5% | -146.7% | -142.2% | -114.3% | -136.3% | -148.4% | -109.0% |
| Current Ratio | 0.16x | 0.18x | 0.20x | 0.24x | 0.25x | 0.13x | 0.14x | 0.14x |
| Quick Ratio | 0.16x | 0.17x | 0.19x | 0.23x | 0.24x | 0.12x | 0.14x | 0.14x |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | -- | -100.0% | -100.1% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -100.0% | -100.1% |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -187.2% | -- | -- | -- |